Email ID
Password
Scrip   
Ark Therapeutics gears up its infrastructure for Cerepro
27 August 2009
Sita Shah

Ark Therapeutics is preparing for the launch of Cerepro (stimagene ceradenovec) ahead of a European approval decision, which is expected at the end of this year.

The malignant glioma treatment will be Ark's first major product and, if approved, would be the first gene-based therapy in Europe....



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36